282 related articles for article (PubMed ID: 17667604)
1. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
3. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
4. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
Chacón M; Roca E; Huertas E; Loria FS; Domenechini E
J Clin Oncol; 2005 Mar; 23(7):1580-2. PubMed ID: 15735135
[No Abstract] [Full Text] [Related]
5. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
Zhu J; Wang Y; Hou M; Li HY; Zhang J
Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
Fiorentini G; Bernardeschi P; De Simone M; Rossi S; Dentico P; Biancalani M; Scuderi S; Vaira M; Palomba A
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):13-6. PubMed ID: 16767899
[No Abstract] [Full Text] [Related]
8. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients].
Bar-Sela G; Lev LM; Kuten A; Wollner M; Haim N
Harefuah; 2006 Jan; 145(1):2-7, 80. PubMed ID: 16450715
[TBL] [Abstract][Full Text] [Related]
10. Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess.
Jain P; Jha AK; Rai RR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):121-2. PubMed ID: 19337651
[No Abstract] [Full Text] [Related]
11. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].
Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926
[TBL] [Abstract][Full Text] [Related]
12. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
[TBL] [Abstract][Full Text] [Related]
13. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
[TBL] [Abstract][Full Text] [Related]
14. [A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].
Hori K; Hanada N; Kusano S; Tsurumoto Y; Sakashita N; Uchino R
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1749-51. PubMed ID: 18931581
[TBL] [Abstract][Full Text] [Related]
15. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
17. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
Papaxoinis G; Nikolaou M; Lianos E; Gaglia A; Economopoulos T; Pectasides D
Anticancer Res; 2006; 26(6C):4869-72. PubMed ID: 17214353
[TBL] [Abstract][Full Text] [Related]
18. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
Tsutsui M; Yoshino S; Sakamoto K; Oka M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2351-3. PubMed ID: 20037419
[TBL] [Abstract][Full Text] [Related]
19. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
